GRDN Guardian Pharmacy Services, Inc.

$28.37

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About Guardian Pharmacy Services, Inc.

No Company Description Available

Website: N/A

Sector
TRADE & SERVICES
Industry
RETAIL-DRUG STORES AND PROPRIETARY STORES
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1802255
Address
300 GALLERIA PARKWAY SE, SUITE 800, ATLANTA, GA, UNITED STATES
Valuation
Market Cap
$1.25B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
9.80
Performance
EPS
$-1.38
Dividend Yield
—
Profit Margin
-7.45%
ROE
0.00%
Technicals
50D MA
$21.84
200D MA
$20.66
52W High
$25.73
52W Low
$14.16
Fundamentals
Shares Outstanding
9M
Target Price
$24.33
Beta
nan

GRDN EPS Estimates vs Actual

● Estimated
● Actual

GRDN News & Sentiment

Nov 11, 2025 • Motley Fool SOMEWHAT-BULLISH
Why Guardian Pharmacy Services Stock Was on a Tear Tuesday
The relatively new healthcare stock was attracting positive attention for a good quarterly earnings report.
Nov 10, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Guardian Pharmacy Services ( GRDN ) Q3 Earnings and Revenues Surpass Estimates
Guardian Pharmacy (GRDN) delivered earnings and revenue surprises of +4.17% and +6.63%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 05, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Catalyst Pharmaceutical ( CPRX ) Beats Q3 Earnings and Revenue Estimates
Catalyst (CPRX) delivered earnings and revenue surprises of +33.33% and +8.77%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 04, 2025 • Zacks Commentary NEUTRAL
Ocular Therapeutix ( OCUL ) Reports Q3 Loss, Tops Revenue Estimates
Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of +5.13% and +8.89%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 03, 2025 • Zacks Commentary NEUTRAL
Guardian Pharmacy Services ( GRDN ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Guardian Pharmacy (GRDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 30, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Indivior PLC ( INDV ) Beats Q3 Earnings and Revenue Estimates
Indivior (INDV) delivered earnings and revenue surprises of +89.47% and +20.81%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Sentiment Snapshot

Average Sentiment Score:

0.123
17 articles with scored sentiment

Overall Sentiment:

Neutral

GRDN Reported Earnings

Aug 11, 2025
Jun 30, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.22
  • Estimate: $0.21
  • Whisper: —
  • Surprise %: 2.3%
May 12, 2025
Mar 31, 2025 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.21
  • Estimate: $0.22
  • Whisper: —
  • Surprise %: -5.9%
Mar 26, 2025
Dec 31, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $0.24
  • Estimate: $0.22
  • Whisper: —
  • Surprise %: 8.2%
Nov 12, 2024
Sep 30, 2024 (Pre market)
0.09 Surprise
  • Reported EPS: $0.28
  • Estimate: $0.19
  • Whisper: —
  • Surprise %: 44.7%

Financials